Who is sponsoring NCT01155986?

NCT01155986 is sponsored by Grünenthal GmbH.

What condition does NCT01155986 study?

NCT01155986 studies Pain, Chronic Pain, Neuropathic Pain, Postoperative Pain.

What drugs are being tested in NCT01155986?

Interventions: Lidocaine 5% medicated plaster, Placebo topical plaster.

What is the status of NCT01155986?

NCT01155986 is currently TERMINATED.

Last reviewed 2019-10-14 · How we verify

Lidocaine 5% Medicated Plaster for the Topical Treatment of Localized Chronic Postoperative Neuropathic Pain.

NCT01155986 Phase 2 TERMINATED

The purpose of this trial is to investigate the efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain in comparison to placebo plaster.

Details

Lead sponsor	Grünenthal GmbH
Phase	Phase 2
Status	TERMINATED
Enrolment	74
Start date	2010-08
Completion	2012-11

Conditions

Pain
Chronic Pain
Neuropathic Pain
Postoperative Pain

Interventions

Lidocaine 5% medicated plaster
Placebo topical plaster

Primary outcomes

Analgesic efficacy of lidocaine 5% medicated plaster in comparison to placebo in subjects with moderate to severe localized chronic postoperative neuropathic pain — daily assessments over 4 weeks
Participants will be selected based on their medical history and clinical examination. A questionnaire called DN4, which stands for 'douleur neuropathique 4' (i.e., '4 questions neuropathic pain will be used to identify subjects with neuropathic pain.) Pain will be assessed on and 11-point numerical rating scale (0 = no pain, 10 = worst pain imaginable). Efficacy of the treatment (i.e., reduction of neuropathic pain) will be evaluated with the 11-point numeric rating scale (NRS).

Countries

France